用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
QUADRA LOGIC TECH INC(2)
Qlt, Inc.(1)
QUADRA LOGIC TECH INC [CA](1)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Verteporfin'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
尾页
共
4
条记录, 当前第1/1页。
公开号
公开日
申请号
申请日
1.
MX2011006376A
2012/12/17
MX20110006376
2011/6/14
专利标题
:COMBINATION OF PHOTODYNAMIC THERAPY AND ANTI-VEGF AGENTS IN THE TREATMENT OF UNWANTED CHOROIDAL NEOVASCULATURE.
专利权人
:
QUADRA LOGIC TECH INC [CA]
;
The use of a combination of photodynamic therapy and an anti-VEGF agent in the treatment of conditions characterized by unwanted choroidal neovasculature is described. These conditions include wet age-related macular degeneration Preferred anti-VEGF agents are antibodies such as bevacizumab or ranibizumab Photosensitizers may be selected from green porphyrins such as BPD-MA (verteporfin) and the photodynamic activation of the photosensitizer may be accomplished using a reduced fluence rate. The ...
2.
EP1755676B1
2012/11/28
专利标题
:Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied verteporfin and/or lemuteporfin
专利权人
:
Qlt, Inc.
;
The present method involves the photodynamic treatment of hyperactive gland disorders. The method involves the topical administration of a photosensitizer composition comprising hydrophobic and/or lipophilic green porphyrins such as lemuteporfin polyethylene glycol and skin penetration enhancers such as oleyl alcohol and TRANSCUTOLTM to affected skin and subsequent exposure of that skin to energy of a wavelength capable of activating the photosensitizer.
3.
CN102325550A
2012/1/18
CN20098156858
2009/12/16
专利标题
:Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature
专利权人
:
QUADRA LOGIC TECH INC
;
4.
AU2009327266A1
2011/7/14
AU20090327266
2009/12/16
专利标题
:Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature
专利权人
:
QUADRA LOGIC TECH INC
;
The use of a combination of photodynamic therapy and an anti-VEGF agent in the treatment of conditions characterized by unwanted choroidal neovasculature is described. These conditions include wet age-related macular degeneration Preferred anti-VEGF agents are antibodies such as bevacizumab or ranibizumab Photosensitizers may be selected from green porphyrins such as BPD-MA (verteporfin) and the photodynamic activation of the photosensitizer may be accomplished using a reduced fluence rate. The ...
首页
1
尾页
共
4
条记录, 当前第1/1页。
当前查询条件: [药品] 包含 'Verteporfin'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文